{"url_path":"/sec/rtgn/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1836295/0001493152-26-024649-index.html","accession_number":"0001493152-26-024649","cik":"0001836295","ticker":"RTGN","issuer_name":"RetinalGenix Technologies Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1836295/0001493152-26-024649-index.html","primary_entity_key":"0001836295","primary_entity_name":"RetinalGenix Technologies Inc."},"word_count":27,"has_tables":true,"body_markdown":"**ITEM\n2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**\n\n \n\nThere\nwere no sales of unregistered equity securities during the three months ended March 31, 2026."}